SCHEMBL6509136

SCHEMBL6509136

CCCn1c(=O)c2[nH]c(-c3ccc(OC(C)C(=O)N4CCN(c5ccccc5)CC4)cc3)cc2n(CCC)c1=O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ADORA2B P29275 19/20 1.00
ADORA2A P29274 18/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6505612 0.91 ADORA2A (0.84) ADORA2BADORA2A
SCHEMBL6503190 0.91 ADORA2A (0.83) ADORA2BADORA2A
SCHEMBL6510839 0.86 ADORA2B (1.00) ADORA2BADORA2A
SCHEMBL6506369 0.85 ADORA2B (1.00) ADORA2BADORA2A
SCHEMBL6510809 0.85 ADORA2B (1.00) ADORA2BADORA2A
SCHEMBL6509045 0.83 ADORA2A (1.00) ADORA2BADORA2A
SCHEMBL6504543 0.83 ADORA2B (0.84) ADORA2BADORA2A
SCHEMBL6508771 0.81 ADORA2A (0.76) ADORA2BADORA2A
SCHEMBL6509264 0.81 ADORA2B (1.00) ADORA2BADORA2A
SCHEMBL6529602 0.80 ADORA2A (0.70) ADORA2BADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050070558-A1 6-Phenyldihydropyrrolopyrimidinedione derivatives ALMIRALL PRODESFARMA S.A. (ES) 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070558-A1 6-Phenyldihydropyrrolopyrimidinedione derivatives ADORA1, ADORA2A, P2RY10 ADORA2B 4/4885ADORA2A 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.